Prevalence and Overlap of Potential Embolic Sources in Patients With Embolic Stroke of Undetermined Source
Authors:
Open Access
- 6 August 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (15) , e012858
Abstract
Background: We aimed to assess the prevalence and degree of overlap of potential embolic sources ( PES ) in patients with embolic stroke of undetermined source ( ESUS ). Methods and Results: In a pooled data set derived from 3 prospective stroke registries, patients were categorized in ≥1 groups according to the PES that was/were identified. We categorized PES as follows: atrial cardiopathy, atrial fibrillation diagnosed during follow‐up, arterial disease, left ventricular disease, cardiac valvular disease, patent foramen ovale, and cancer. In 800 patients with ESUS (43.1% women; median age, 67.0 years), 3 most prevalent PES were left ventricular disease, arterial disease, and atrial cardiopathy, which were present in 54.4%, 48.5%, and 45.0% of patients, respectively. Most patients (65.5%) had >1 PES , whereas only 29.7% and 4.8% of patients had a single or no PES , respectively. In 31.1% of patients, there were ≥3 PES present. On average, each patient had 2 PES (median, 2). During a median follow‐up of 3.7 years, stroke recurrence occurred in 101 (12.6%) of patients (23.3 recurrences per 100 patient‐years). In multivariate analysis, the risk of stroke recurrence was higher in the atrial fibrillation group compared with other PES , but not statistically different between patients with 0 to 1, 2, or ≥3 PES . Conclusions: There is major overlap of PES in patients with ESUS . This may possibly explain the negative results of the recent large randomized controlled trials of secondary prevention in patients with ESUS and offer a rationale for a randomized controlled trial of combination of anticoagulation and aspirin for the prevention of stroke recurrence in patients with ESUS . Clinical Trial Registration: URL : http://www.clinicaltrials.gov . Unique identifier: NCT 02766205.Keywords
This publication has 28 references indexed in Scilit:
- Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialEuropean Stroke Journal, 2016
- Premature Atrial Contractions on the Screening Electrocardiogram and Risk of Ischemic Stroke: The Reasons for Geographic and Racial Differences in Stroke StudyNeuroepidemiology, 2016
- Embolic Strokes of Undetermined Source in the Athens Stroke RegistryStroke, 2015
- Left Atrial Enlargement and Stroke RecurrenceStroke, 2015
- Embolic Strokes of Undetermined Source in the Athens Stroke RegistryStroke, 2015
- Embolic strokes of undetermined source: the case for a new clinical constructThe Lancet Neurology, 2014
- Association Between Obesity and Mortality After Acute First-Ever StrokeStroke, 2011
- The Acute STroke Registry and Analysis of Lausanne (ASTRAL)Stroke, 2010
- Atherosclerotic Disease of the Aortic Arch and the Risk of Ischemic StrokeNew England Journal of Medicine, 1994
- The Prevalence of Ulcerated Plaques in the Aortic Arch in Patients with StrokeNew England Journal of Medicine, 1992